Wall Street lays out 3 key reasons to doubt an AstraZeneca-Gilead megamerger, which would likely be the largest-ever deal in the biopharma industry (GILD, AZN)

6:20am PDT - June 8th, 2020    remdesivir - Business Insider

• Wall Street analysts are skeptical that an AstraZeneca-Gilead megamerger can be done. 
• The British pharma giant AstraZeneca approached Gilead last month about a potential merger, Bloomberg News reported on Sunday. 
• Such a deal faces…